⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3292391 | 0.73 | — | — | |
| SCHEMBL7080542 | 0.71 | — | — | |
| SCHEMBL65965 | 0.71 | — | — | |
| SCHEMBL28386893 | 0.69 | — | — | |
| SCHEMBL2104477 | 0.69 | — | — | |
| Hydrochloric Acid SCHEMBL7524961 | 0.69 | — | — | |
| SCHEMBL4581130 | 0.69 | — | — | |
| SCHEMBL8083381 | 0.69 | — | — | |
| SCHEMBL15261006 | 0.69 | — | — | |
| SCHEMBL24458127 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115181077-A | Synthetic method of vortioxetine with low impurity content | 安徽峆一药业股份有限公司 | 2022-10-14 | — | — | CN | claimed |
| CN-119285696-A | Preparation method of carbon dioxide response type organic nanotube | 华东理工大学 | 2025-01-10 | — | — | CN | disclosed |
| US-20230157166-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2023-05-18 | — | — | US | disclosed |
| US-20230157166-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2023-05-18 | — | — | US | disclosed |
| US-10703746-B2 | Mutant IDH1 inhibitors useful for treating cancer | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2020-07-07 | — | — | US | disclosed |
| US-10421954-B2 | Hybrid polymers, pharmaceutical compositions and methods of synthesizing the same | NEW YORK UNIVERSITY (US) | 2019-09-24 | — | — | US | disclosed |
| WO-2018102885-A1 | MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS AND USES THEREOF | BIONOMICS LIMITED (AU) | 2018-06-14 | — | — | WO | disclosed |
| US-20170015991-A1 | HYBRID POLYMERS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF SYNTHESIZING THE SAME | NEW YORK UNIVERSITY | 2017-01-19 | — | — | US | disclosed |
| US-9458449-B2 | Hybrid polymers, pharmaceutical compositions and methods of synthesizing the same | NEW YORK UNIVERSITY (US) | 2016-10-04 | — | — | US | disclosed |
| US-20150044189-A1 | HYBRID POLYMERS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF SYNTHESIZING THE SAME | NEW YORK UNIVERSITY | 2015-02-12 | — | — | US | disclosed |
| US-8138330-B2 | Solid phase synthesis via deblocking immobilized nucleoside, then coupling acyl protected nucleoside phosphoramidite | SIGMA-ALDRICH CO. LLC (US) | 2012-03-20 | — | — | US | disclosed |
| WO-2008043853-A2 | PHOTOCHROMIC FILM | OPCO GMBH (DE) | 2008-04-17 | — | — | WO | disclosed |
| US-20080064867-A1 | PROCESS FOR THE SYNTHESIS OF OLIGONUCLEOTIDES | SIGMA ALDRICH COMPANY (US) | 2008-03-13 | — | — | US | disclosed |
| CN-1370154-A | Aminothiazole derivatives and their use as CRF receptor ligands | SANOFI SYNTHELABO (FR) | 2002-09-18 | — | — | CN | disclosed |
| US-5191015-A | Solid phase synthesis on crosslinked polymer, removal of crosslinks to solubilize | MEDICAL RESEARCH COUNCIL (GB) | 1993-03-02 | — | — | US | disclosed |
| EP-0394318-A1 | POLYMERS AND POLYMER-PEPTIDE CONJUGATES | MEDICAL RESEARCH COUNCIL (GB) | 1990-10-31 | — | — | EP | disclosed |
| WO-1989005305-A1 | POLYMERS AND POLYMER-PEPTIDE CONJUGATES | 3I RESEARCH EXPLOITATION LIMITED (GB) | 1989-06-15 | — | — | WO | disclosed |
| US-4508861-A | CONTAINING ANTIOXIDANT SELECTED FROM HINDERED PHENOLS, ARYL PHOSPHONITES, ORGANIC PHOSPHITES, THIOESTERS OR MIXTURES | GENERAL ELECTRIC COMPANY (US) | 1985-04-02 | — | — | US | disclosed |